TIMOTHY FRANKS: Open Payments
NPI 1447917919 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 7 payments from 6 companies in 2025. Trend: 2023 $267 · 2024 $0 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Lilly USA, LLC | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
Products named: JARDIANCE, PREVYMIS, Ozempic, Vanrafia, Fabhalta, Kerendia, TARPEYO.
Industry payments across RI — which companies pay providers there.
